Transcriptional regulation of interleukin-2 gene expression is impaired by copper deficiency in Jurkat human T lymphocytes

J Nutr. 1999 Mar;129(3):596-601. doi: 10.1093/jn/129.3.596.

Abstract

Copper deficiency reduces secretion of the cytokine interleukin-2 (IL-2) by activated rodent splenocytes, human peripheral blood mononuclear cells and Jurkat cells, a human T lymphocyte cell line. Previous studies showed that low Cu status also decreased the level of IL-2 mRNA in activated Jurkat cells by 50%. Synthesis of this cytokine is regulated by alterations in transcription of the IL-2 gene and the stability of IL-2 mRNA. To determine if Cu status influenced promoter activity of the IL-2 gene, Jurkat cells were transfected with a luciferase reporter gene construct containing the entire 300 bp human IL-2 promoter/enhancer sequence. Cu deficiency was induced by incubating stably transfected cells with the Cu chelator 2,3,2-tetraamine for 35 h prior to activating cells with phytohemagglutinin-P and phorbol myristate acetate. Luciferase activity in lysates of Cu-deficient cells was approximately 50% lower in several multiclonal and clonal cell lines of stably transfected cells than in replicate cultures that were not exposed to chelator. The relative levels of endogenous IL-2 bioactivity and luciferase activity were highly correlated in the transfected cell lines. The chelator-mediated reduction in reporter gene activity was dose-dependent at levels of 5-40 micromol 2,3,2-tetraamine/L. The addition of a slight molar excess of Cu, but not Zn or Fe, to medium containing 2,3,2-tetraamine prevented the decline in luciferase activity. IL-2 mRNA stability in parental Jurkat cells was independent of Cu status. These data indicate that decreased cellular Cu attenuates IL-2 synthesis in T lymphocytes by inhibiting transcription of the IL-2 gene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chelating Agents / pharmacology
  • Copper / deficiency*
  • Dichlororibofuranosylbenzimidazole / pharmacology
  • Gene Expression Regulation*
  • Genes, Reporter
  • Glyceraldehyde-3-Phosphate Dehydrogenases / genetics
  • Humans
  • Interleukin-2 / genetics*
  • Jurkat Cells / metabolism*
  • Luciferases / genetics
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • Phytohemagglutinins / pharmacology
  • RNA, Messenger / metabolism
  • Superoxide Dismutase / metabolism
  • T-Lymphocytes / metabolism*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transcription, Genetic*
  • Transfection

Substances

  • Chelating Agents
  • Interleukin-2
  • Nucleic Acid Synthesis Inhibitors
  • Phytohemagglutinins
  • RNA, Messenger
  • Dichlororibofuranosylbenzimidazole
  • Copper
  • Luciferases
  • Superoxide Dismutase
  • Glyceraldehyde-3-Phosphate Dehydrogenases
  • Tetradecanoylphorbol Acetate